help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints, Permissions and Rights
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Masuyama, H.
Right arrow Articles by MacDonald, P. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Masuyama, H.
Right arrow Articles by MacDonald, P. N.
Molecular Endocrinology 14 (3): 421-428
Copyright © 2000 by The Endocrine Society

Endocrine Disrupting Chemicals, Phthalic Acid and Nonylphenol, Activate Pregnane X Receptor-Mediated Transcription

Hisashi Masuyama, Yuji Hiramatsu, Mamoru Kunitomi, Takafumi Kudo and Paul N. MacDonald

Department of Obstetrics and Gynecology (H.M., Y.H., M.K., T.K.) Okayama University Medical School Okayama, 700-8558, Japan
Department of Pharmacology (P.N.M.) Case Western Reserve University Cleveland, Ohio 44106

Recently, Pregnane X receptor (PXR), a new member of the nuclear receptor superfamily, was shown to mediate the effects of several steroid hormones, such as progesterone, glucocorticoid, pregnenolone, and xenobiotics on cytochrome P450 3A genes (CYP3A) through the specific DNA sequence for CYP3A, suggesting that PXR may play a role in steroid hormone metabolism. In this paper, we demonstrated that phthalic acid and nonylphenol, endocrine-disrupting chemicals (EDCs), stimulated PXR-mediated transcription at concentrations comparable to those at which they activate estrogen receptor-mediated transcription using a transient reporter gene expression assay in COS-7 cells. However, bisphenol A, another EDC, had no effect on PXR-mediated transcription, although this chemical significantly enhanced ER-mediated transcription. In the yeast two-hybrid protein interaction assay, PXR interacted with two nuclear receptor coactivator proteins, steroid hormone receptor coactivator-1 and receptor interacting protein 140, in the presence of phthalic acid or nonylphenol. Thus, EDC-occupied PXR may regulate its specific gene expression through the receptor-coactivator interaction. In contrast, these EDCs had no effect on the interaction between PXR and suppressor for gal 1, a component of proteasome. Finally, the expression of CYP3A1 mRNA in the liver of rats exposed to phthalic acid or nonylphenol markedly increased compared with that in rats treated with estradiol, bisphenol A, or ethanol as assessed by competitive RT-PCR. These data suggest that EDCs may affect endocrine functions by altering steroid hormone metabolism through PXR.




This article has been cited by other articles:


Home page
 Lab AnimHome page
Z Li, S Okano, K Yoshinari, T Miyamoto, Y Yamazoe, K Shinya, K Ioku, and N Kasai
Soft-hydrothermal processing of red cedar bedding reduces its induction of cytochrome P450 in mouse liver
Lab Anim, April 1, 2009; 43(2): 205 - 211.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
R. Maravilla-Galvan, R. Fierro, H. Gonzalez-Marquez, S. Gomez-Arroyo, I. Jimenez, and M. Betancourt
Effects of Atrazine and Fenoxaprop-Ethyl on Capacitation and the Acrosomal Reaction in Boar Sperm
International Journal of Toxicology, January 1, 2009; 28(1): 24 - 32.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
B. W. Cooper, T. M. Cho, P. M. Thompson, and A. D. Wallace
Phthalate Induction of CYP3A4 is Dependent on Glucocorticoid Regulation of PXR Expression
Toxicol. Sci., June 1, 2008; 103(2): 268 - 277.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
H. Masuyama, H. Nakatsukasa, N. Takamoto, and Y. Hiramatsu
Down-Regulation of Pregnane X Receptor Contributes to Cell Growth Inhibition and Apoptosis by Anticancer Agents in Endometrial Cancer Cells
Mol. Pharmacol., October 1, 2007; 72(4): 1045 - 1053.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Pharmacol.Home page
S. Ekins, C. Chang, S. Mani, M. D. Krasowski, E. J. Reschly, M. Iyer, V. Kholodovych, N. Ai, W. J. Welsh, M. Sinz, et al.
Human Pregnane X Receptor Antagonists and Agonists Define Molecular Requirements for Different Binding Sites
Mol. Pharmacol., September 1, 2007; 72(3): 592 - 603.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. P. Hernandez, W. Huang, L. M. Chapman, S. Chua, D. D. Moore, and W. S. Baldwin
The Environmental Estrogen, Nonylphenol, Activates the Constitutive Androstane Receptor
Toxicol. Sci., August 1, 2007; 98(2): 416 - 426.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
H. K. Choi, J. W. Yang, S. H. Roh, C. Y. Han, and K. W. Kang
Induction of multidrug resistance associated protein 2 in tamoxifen-resistant breast cancer cells
Endocr. Relat. Cancer, June 1, 2007; 14(2): 293 - 303.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
M. M. Tabb and B. Blumberg
New Modes of Action for Endocrine-Disrupting Chemicals
Mol. Endocrinol., March 1, 2006; 20(3): 475 - 482.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
J. Orans, D. G. Teotico, and M. R. Redinbo
The Nuclear Xenobiotic Receptor Pregnane X Receptor: Recent Insights and New Challenges
Mol. Endocrinol., December 1, 2005; 19(12): 2891 - 2900.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
M. E. Wyde, S. E. Kirwan, F. Zhang, A. Laughter, H. B. Hoffman, E. Bartolucci-Page, K. W. Gaido, B. Yan, and L. You
Di-n-Butyl Phthalate Activates Constitutive Androstane Receptor and Pregnane X Receptor and Enhances the Expression of Steroid-Metabolizing Enzymes in the Liver of Rat Fetuses
Toxicol. Sci., August 1, 2005; 86(2): 281 - 290.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
H. Masuyama, N. Suwaki, Y. Tateishi, H. Nakatsukasa, T. Segawa, and Y. Hiramatsu
The Pregnane X Receptor Regulates Gene Expression in a Ligand- and Promoter- Selective Fashion
Mol. Endocrinol., May 1, 2005; 19(5): 1170 - 1180.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
C. A. Vyhlidal, P. K. Rogan, and J. S. Leeder
Development and Refinement of Pregnane X Receptor (PXR) DNA Binding Site Model Using Information Theory: INSIGHTS INTO PXR-MEDIATED GENE REGULATION
J. Biol. Chem., November 5, 2004; 279(45): 46779 - 46786.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
H. Masuyama and Y. Hiramatsu
Involvement of Suppressor for Gal 1 in the Ubiquitin/Proteasome-mediated Degradation of Estrogen Receptors
J. Biol. Chem., March 26, 2004; 279(13): 12020 - 12026.
[Abstract] [Full Text] [PDF]

Home page
 Pharmacol. Rev.Home page
C. Handschin and U. A. Meyer
Induction of Drug Metabolism: The Role of Nuclear Receptors
Pharmacol. Rev., December 1, 2003; 55(4): 649 - 673.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Luo, R. Sladek, J. Carrier, J.-A. Bader, D. Richard, and V. Giguere
Reduced Fat Mass in Mice Lacking Orphan Nuclear Receptor Estrogen-Related Receptor {alpha}
Mol. Cell. Biol., November 15, 2003; 23(22): 7947 - 7956.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
H. Masuyama, Y. Hiramatsu, J.-i. Kodama, and T. Kudo
Expression and Potential Roles of Pregnane X Receptor in Endometrial Cancer
J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4446 - 4454.
[Abstract] [Full Text] [PDF]

Home page
 International Journal of ToxicologyHome page
M. R. Lee, Y. J. Kim, D. Y. Hwang, T. S. Kang, J. H. Hwang, C. H. Lim, H. K. Kang, J. S. Goo, H. J. Lim, K. S. Ahn, et al.
An In Vitro Bioassay for Xenobiotics Using the SXR-Driven Human CYP3A4/lac Z Reporter Gene
International Journal of Toxicology, May 1, 2003; 22(3): 207 - 213.
[Abstract] [PDF]

Home page
 Mol. Pharmacol.Home page
K. Kawana, T. Ikuta, Y. Kobayashi, O. Gotoh, K. Takeda, and K. Kawajiri
Molecular Mechanism of Nuclear Translocation of an Orphan Nuclear Receptor, SXR
Mol. Pharmacol., March 1, 2003; 63(3): 524 - 531.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
S.-J. Lee and D. R. Buhler
Functional Properties of a Rainbow Trout CYP3A27 Expressed by Recombinant Baculovirus in Insect Cells
Drug Metab. Dispos., December 1, 2002; 30(12): 1406 - 1412.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
K. Moriyama, T. Tagami, T. Akamizu, T. Usui, M. Saijo, N. Kanamoto, Y. Hataya, A. Shimatsu, H. Kuzuya, and K. Nakao
Thyroid Hormone Action Is Disrupted by Bisphenol A as an Antagonist
J. Clin. Endocrinol. Metab., November 1, 2002; 87(11): 5185 - 5190.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
S. A. Kliewer, B. Goodwin, and T. M. Willson
The Nuclear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism
Endocr. Rev., October 1, 2002; 23(5): 687 - 702.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K.-H. Song, K. Lee, and H.-S. Choi
Endocrine Disrupter Bisphenol A Induces Orphan Nuclear Receptor Nur77 Gene Expression and Steroidogenesis in Mouse Testicular Leydig Cells
Endocrinology, June 1, 2002; 143(6): 2208 - 2215.
[Abstract] [Full Text] [PDF]

Home page
 J. Lipid Res.Home page
S. A. Kliewer and T. M. Willson
Regulation of xenobiotic and bile acid metabolism by the nuclear pregnane X receptor
J. Lipid Res., March 1, 2002; 43(3): 359 - 364.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
H. Masuyama, H. Inoshita, Y. Hiramatsu, and T. Kudo
Ligands Have Various Potential Effects on the Degradation of Pregnane X Receptor by Proteasome
Endocrinology, January 1, 2002; 143(1): 55 - 61.
[Abstract] [Full Text] [PDF]

Home page
 Drug Metab. Dispos.Home page
L. C. Quattrochi and P. S. Guzelian
CYP3A Regulation: From Pharmacology to Nuclear Receptors
Drug Metab. Dispos., April 13, 2001; 29(5): 615 - 622.
[Abstract] [Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society